feed,title,long_url,short_url
Benzinga,FDA To Review Two Cell Therapies For Multiple Myeloma This Week - Johnson & Johnson And Bristol-Myers,https://benzinga.com/general/biotech/24/03/37671173/fda-to-review-two-cell-therapies-for-multiple-myeloma-this-week-johnson-johnson-and-bristol-myers,https://da.gd/y1hMr
Benzinga,Marathon Oil Hits The Ground Running: Analyst Boosts Forecast Amid Strong Reserve Report,https://benzinga.com/analyst-ratings/analyst-color/24/03/37671106/marathon-oil-hits-the-ground-running-analyst-boosts-forecast-amid-strong-reserve-re,https://da.gd/hcOd
